Fig. 2.
Probability of continuous complete remission of 12 adult patients with pro-B ALL treated in GMALL study 03/87 (0.10; median, 420 days) and of 30 adult patients with pro-B ALL treated in GMALL study 04/89 (0.52; median, not yet reached). P (log-rank) = .04.